PE20071137A1 - Derivados de 8-piracin-s-espiropirimidintriona oxaquinolina como agentes antibacterianos - Google Patents
Derivados de 8-piracin-s-espiropirimidintriona oxaquinolina como agentes antibacterianosInfo
- Publication number
- PE20071137A1 PE20071137A1 PE2006001657A PE2006001657A PE20071137A1 PE 20071137 A1 PE20071137 A1 PE 20071137A1 PE 2006001657 A PE2006001657 A PE 2006001657A PE 2006001657 A PE2006001657 A PE 2006001657A PE 20071137 A1 PE20071137 A1 PE 20071137A1
- Authority
- PE
- Peru
- Prior art keywords
- antibacterial agents
- spiropyrimidintriona
- oxaquinoline
- piracin
- derivatives
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title abstract 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical class [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A COMPUESTOS DE FORMULA (I), EN DONDE R1 ES PIRACINA OPCIONALMENTE SUSTITUIDA; R2 Y R3 SON INDEPENDIENTEMENTE H, ALQUILO(C1-C6) OPCIONALMENTE SUSTITUIDOS; R4 Y R5 SON INDEPENDIENTEMENTE H, ALQUILO(C1-C6), ETER, -(CH2)mARILO, BENCILO, -(CH2)mOPO3(Rp)2', OPCIONALMENTE SUSTITUIDOS, ENTRE OTROS; X E Y SON INDEPENDIENTEMENTE H, HALO, ALQUILO(C1-C6), -OR6', ETER, HETEROCICLICO, ENTRE OTROS. SON SELECCIONADOS: rel-(2S,4R,4aR)-9,10-DIFLUORO-2,4-DIMETIL-8-PIRACIN-2-IL-1,2,4,4a-TETRAHIDRO-2'H,6H-ESPIRO[1,4-OXACIN[4,3-a]QUINOLIN-5-5'-PIRIMIDIN]-2',4',6'(1'H,3'H)-TRIONA, (2S,4R,4aR)-9,10-DIFLUORO-2,4-DIMETIL-8-PIRACIN-2-IL-1,2,4,4a-TETRAHIDRO-2'H,6H-ESPIRO[1,4-OXACIN[4,3-a]QUINOLIN-5-5'-PIRIMIDIN]-2',4',6'(1'H,3'H)-TRIONA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON AGENTES ANTIBACTERIANOS POR LO QUE SON UTILES EN EL TRATAMIENTO DE INFECCIONES BACTERIANAS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75326205P | 2005-12-22 | 2005-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20071137A1 true PE20071137A1 (es) | 2008-01-10 |
Family
ID=37872452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006001657A PE20071137A1 (es) | 2005-12-22 | 2006-12-20 | Derivados de 8-piracin-s-espiropirimidintriona oxaquinolina como agentes antibacterianos |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7557100B2 (es) |
| EP (2) | EP1971612A1 (es) |
| JP (1) | JP5513743B2 (es) |
| AR (1) | AR058701A1 (es) |
| CA (1) | CA2634644A1 (es) |
| DO (1) | DOP2006000268A (es) |
| GT (1) | GT200600520A (es) |
| NL (1) | NL2000373C2 (es) |
| PE (1) | PE20071137A1 (es) |
| TW (1) | TW200734344A (es) |
| UY (1) | UY30030A1 (es) |
| WO (1) | WO2007072151A1 (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004080391A2 (en) | 2003-03-10 | 2004-09-23 | Optimer Pharmaceuticals, Inc. | Novel antibacterial agents |
| DOP2006000268A (es) * | 2005-12-22 | 2007-07-31 | Pfizer Prod Inc | Agentes antibacterianos |
| CN101784553A (zh) * | 2007-07-02 | 2010-07-21 | 阿斯利康(瑞典)有限公司 | 3-螺嘧啶三酮-喹啉衍生物及其作为抗菌药物的应用 |
| DK2164964T3 (da) * | 2007-07-06 | 2011-12-05 | Univ Aarhus | Dehydrerede chitosanpartikler |
| US20110178064A1 (en) | 2007-07-16 | 2011-07-21 | Astrazeneca R&D | Spiro condensed barbituric acid derivatives for use as antibacterial |
| US9453042B2 (en) * | 2007-10-25 | 2016-09-27 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
| US9040528B2 (en) | 2008-10-14 | 2015-05-26 | Astrazeneca Ab | Chemical compounds 542 |
| US8658641B2 (en) * | 2008-10-14 | 2014-02-25 | Astrazeneca Ab | Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| CN102245195B (zh) | 2008-10-24 | 2016-01-13 | 森普拉制药公司 | 使用含三唑的大环内酯的生物防御 |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| CN102724874B (zh) | 2009-09-10 | 2018-06-01 | 森普拉制药公司 | 治疗疟疾、结核病和mac疾病的方法 |
| PL2550286T3 (pl) | 2010-03-22 | 2016-07-29 | Cempra Pharmaceuticals Inc | Krystaliczne postaci makrolidu i ich zastosowanie |
| CA2799937A1 (en) | 2010-05-20 | 2011-11-24 | Cempra Pharmaceuticals, Inc. | Processes for preparing macrolides and ketolides and intermediates therefor |
| JP6042334B2 (ja) | 2010-09-10 | 2016-12-14 | センプラ ファーマシューティカルズ，インコーポレイテッド | 疾患治療のための水素結合形成フルオロケトライド |
| SG11201405895UA (en) | 2012-03-27 | 2014-10-30 | Cempra Pharmaceuticals Inc | Parenteral formulations for administering macrolide antibiotics |
| US8952149B2 (en) | 2012-09-26 | 2015-02-10 | Zoetis Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| US8889671B2 (en) * | 2013-01-23 | 2014-11-18 | Astrazeneca Ab | Compounds and methods for treating bacterial infections |
| RU2015138796A (ru) | 2013-03-14 | 2017-04-19 | Семпра Фармасьютикалс, Инк. | Способы и составы для лечения респираторных заболеваний |
| HK1218864A1 (zh) | 2013-03-15 | 2017-03-17 | 森普拉制药公司 | 用於制备大环内酯抗菌剂的收敛方法 |
| KR20170007818A (ko) | 2014-05-29 | 2017-01-20 | 엔타시스 테라퓨틱스 리미티드 | 박테리아 감염의 치료를 위한 융합된，스피로환식 헤테로방향족 화합물 |
| TW201722965A (zh) | 2015-08-16 | 2017-07-01 | 葛蘭素史密斯克藍智慧財產發展有限公司 | 用於抗菌應用之化合物 |
| PT3658557T (pt) | 2017-07-28 | 2024-09-11 | Nimbus Lakshmi Inc | Inibidores de tyk2 e usos dos mesmos |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5011860A (en) | 1986-04-11 | 1991-04-30 | Schering Corporation | Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases |
| DE19502178A1 (de) | 1994-01-27 | 1995-08-03 | Hoechst Ag | Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen |
| US6608081B2 (en) * | 1999-08-12 | 2003-08-19 | Ortho-Mcneil Pharmaceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| MXPA03003735A (es) | 2000-10-26 | 2003-07-28 | Pfizer Prod Inc | Inhibidores de espiropirimidin-2,4,6-triona metaloproteinasas. |
| ATE315038T1 (de) * | 2001-05-30 | 2006-02-15 | Warner Lambert Co | Antibakterielle mittel |
| WO2003091252A1 (en) | 2002-04-25 | 2003-11-06 | Bristol-Myers Squibb Company | Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases |
| US7208490B2 (en) | 2002-10-07 | 2007-04-24 | Pharmacia & Upjohn Company Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| JP2008543739A (ja) | 2005-05-09 | 2008-12-04 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 抗菌剤 |
| DOP2006000268A (es) * | 2005-12-22 | 2007-07-31 | Pfizer Prod Inc | Agentes antibacterianos |
-
2006
- 2006-11-29 DO DO2006000268A patent/DOP2006000268A/es unknown
- 2006-12-11 WO PCT/IB2006/003641 patent/WO2007072151A1/en not_active Ceased
- 2006-12-11 EP EP06831728A patent/EP1971612A1/en not_active Withdrawn
- 2006-12-11 JP JP2008546665A patent/JP5513743B2/ja not_active Expired - Fee Related
- 2006-12-11 EP EP13151044.8A patent/EP2620439A1/en not_active Withdrawn
- 2006-12-11 CA CA002634644A patent/CA2634644A1/en not_active Abandoned
- 2006-12-13 NL NL2000373A patent/NL2000373C2/nl not_active IP Right Cessation
- 2006-12-19 UY UY30030A patent/UY30030A1/es not_active Application Discontinuation
- 2006-12-19 US US11/641,215 patent/US7557100B2/en not_active Expired - Fee Related
- 2006-12-20 GT GT200600520A patent/GT200600520A/es unknown
- 2006-12-20 PE PE2006001657A patent/PE20071137A1/es not_active Application Discontinuation
- 2006-12-20 AR ARP060105669A patent/AR058701A1/es unknown
- 2006-12-21 TW TW095148255A patent/TW200734344A/zh unknown
-
2009
- 2009-07-15 US US12/503,123 patent/US20090275536A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7557100B2 (en) | 2009-07-07 |
| NL2000373C2 (nl) | 2010-02-02 |
| UY30030A1 (es) | 2007-07-31 |
| EP2620439A1 (en) | 2013-07-31 |
| US20070197518A1 (en) | 2007-08-23 |
| WO2007072151A1 (en) | 2007-06-28 |
| JP2009520804A (ja) | 2009-05-28 |
| EP1971612A1 (en) | 2008-09-24 |
| US20090275536A1 (en) | 2009-11-05 |
| GT200600520A (es) | 2007-07-17 |
| JP5513743B2 (ja) | 2014-06-04 |
| NL2000373A1 (nl) | 2007-06-26 |
| TW200734344A (en) | 2007-09-16 |
| AR058701A1 (es) | 2008-02-20 |
| CA2634644A1 (en) | 2007-06-28 |
| DOP2006000268A (es) | 2007-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20071137A1 (es) | Derivados de 8-piracin-s-espiropirimidintriona oxaquinolina como agentes antibacterianos | |
| PE20010544A1 (es) | Derivados de mutilina utiles como agentes antibacterianos | |
| PE20060555A1 (es) | Derivados de pirrol-oxindol como moduladores del receptor de progesterona | |
| PE20081583A1 (es) | Agentes antibacterianos derivados de compuestos carbonilamino | |
| SV2008002969A (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal | |
| BR0017026A (pt) | Lipeptìdeos como agentes antibacterianos | |
| BRPI0412659A (pt) | isÈmero c de cci-779, seu processo de preparação, composição farmacêutica compreendendo o mesmo e pacote farmacêutico contendo o referido composto | |
| AUPR213700A0 (en) | Antiviral agents | |
| PE20090274A1 (es) | Compuestos triciclicos nitrogenados como agentes antibacterianos | |
| EA200301121A1 (ru) | Тартраты 5,8,14-триазатетрацикло[10.3.1.02,11.04,9]гексадека-2(11),3,5,7,9-пентаена | |
| PE20090511A1 (es) | Imidazopiridinonas | |
| PE20070793A1 (es) | Compuestos triciclicos que contienen nitrogeno como agentes antibacterianos | |
| BR0002936A (pt) | Compostos de biciclicarbonil-indol como agentes antiinflamatórios/analgésicos | |
| PE20081831A1 (es) | Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona | |
| PE20081753A1 (es) | Compuestos y composiciones como inhibidores de la proteasa activadora de canal | |
| DE602006006850D1 (de) | Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate | |
| CL2011000784A1 (es) | Compuestos derivados de 7-h-pirazoli[3,4-e]-diasepina-6(5h)-ona sustituidos; procedimiento de preparacion; composicion farmaceutica, utiles como agentes antibacteriales. | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| PE20090110A1 (es) | Compuestos macrociclicos derivados de amina como agentes inhibidores de hsp90 | |
| PA8678901A1 (es) | Derivados de quinolina como agentes antibacteriales | |
| CO5660260A2 (es) | Derivados de benzimidazol, composiciones que los contienen, preparacion y el uso de los mismos | |
| CL2004000979A1 (es) | Nonapeptidos acilados tipo lysobacitina, composicion que los contiene metodo de preparacion, util como bactericida. | |
| CO5660261A2 (es) | Derivados de bencimidazol, composiciones que los contienen, preparacion de estos y usos de estos | |
| PE20050483A1 (es) | Derivados de tetrazol de formula (i), sus composiciones farmaceuticas y procesos para producir composiciones farmaceuticas | |
| PE20080941A1 (es) | Compuestos triciclicos como agonistas del receptor de melatonina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |